Drug application

TEMOZOLOMIDE (TEMOZOLOMIDE)

Drugs@FDA ANDA 203898 · EIRGEN

Key facts

Drug name TEMOZOLOMIDE
Active ingredients TEMOZOLOMIDE
Application type ANDA
Application number 203898
Company EIRGEN
Dosage forms CAPSULE, ORAL
Strength 5MG
Marketing status Discontinued
Reference listed drug No
Latest submission status date Feb 10, 2016

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications